Related references
Note: Only part of the references are listed.Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016
Daniel Hoffman et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience
Faina Nakhlis et al.
BREAST JOURNAL (2020)
Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients
Oluwadamilola M. Fayanju et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database
A. R. Kupstas et al.
BRITISH JOURNAL OF SURGERY (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
Lauren M. Postlewait et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
Dominique J. P. van Uden et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis
Stephanie M. Wong et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer
Sarah M. DeSnyder et al.
CLINICAL BREAST CANCER (2018)
Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes
Tina J. Hieken et al.
CLINICAL BREAST CANCER (2018)
The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study
Mahvish Muzaffar et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2018)
Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database
Jieqiong Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer
Faina Nakhlis et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy
Shannon K. Swisher et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
D. Andreis et al.
BREAST (2016)
Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery
Monika Brzezinska et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research
D. Rea et al.
BRITISH JOURNAL OF CANCER (2015)
Risk factors for developing inflammatory breast cancer: Unique trends among a single patient population
Randie E. White et al.
CANCER RESEARCH (2015)
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
Jean-Francois Boileau et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Challenging a Traditional Paradigm: 12-Year Experience with Autologous Free Flap Breast Reconstruction for Inflammatory Breast Cancer
Edward I. Chang et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database
Natasha M. Rueth et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Thorsten Kuehn et al.
LANCET ONCOLOGY (2013)
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
Nehmat Houssami et al.
EUROPEAN JOURNAL OF CANCER (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Optimal Timing of Delayed Free Lower Abdominal Flap Breast Reconstruction after Postmastectomy Radiation Therapy
Donald P. Baumann et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer
Samir Hidar et al.
INTERNATIONAL JOURNAL OF SURGERY (2009)
Locoregional treatment outcomes after multimodality management of inflammatory breast cancer
Ian J. Bristol et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Post-mastectomy reconstruction: a comparative analysis on psychosocial and psychopathological outcomes
Corrado Rubino et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2007)
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy
BT Hennessy et al.
CANCER (2006)
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer
V Stearns et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Esthetic reconstruction after mastectomy for inflammatory breast cancer: Is it worthwhile?
PL Chin et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)
Share Paper
